New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (?Blue Mystic?)
Open Access
- 1 November 2005
- journal article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 19 (6), 675-679
- https://doi.org/10.1177/0269881105056660
Abstract
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first synthesized in 1986; its desired effects include both a sense of empathy and of well-being. Hallucinations, nausea, anxiety, panic attacks and paranoid ideation are anecdotally reported. According to the different European sources here approached, the availability of 2C-T-7 at street level seems to be currently very low, although one death related to a mono-intoxication with 2C-T-7 has been documented in the USA. With respect to information on 2C-T-7 available online, due to both redundancy and relevance issues the initial identified sample of 360 was reduced to 118 websites. In 14 (11.9%) websites, the detailed description of the 2C-T-7 synthesis was given. Harm Reduction websites appeared significantly earlier in the search engines results’ list than Anti drugs ( p 0.006) websites. Five (4.2%) websites apparently offered 2C-T-7 for sale. The large body of knowledge available online seems to contrast with small numbers of seizures at street level; an exhaustive web mapping of drug-related issues may be of interest for the clinician. Projects aimed at designing more ‘attractive’ prevention websites should be planned and future studies should better assess the characteristics of those consumers who take advantage of the online information of hallucinogenic compounds.This publication has 15 references indexed in Scilit:
- Internet pharmacies and online prescription drug sales: a cross-sectional studyDrugs: Education, Prevention and Policy, 2005
- Stimulus effects of three sulfur-containing psychoactive agentsPharmacology Biochemistry and Behavior, 2004
- Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult usersDrug and Alcohol Dependence, 2004
- Importance of Cyberspace for the Assessment of the Drug Abuse Market: Preliminary Results from the Psychonaut 2002 ProjectCyberPsychology & Behavior, 2003
- Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate ReceptorsNeuropsychopharmacology, 2000
- Agonist-Directed Signaling of Serotonin 5-HT2C Receptors Differences Between Serotonin and Lysergic Acid Diethylamide (LSD)Neuropsychopharmacology, 1999
- Serotonin and HallucinogensNeuropsychopharmacology, 1999
- Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia ResearchPharmacopsychiatry, 1998
- Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogensPsychopharmacology, 1988
- Acquired and Crossed Tolerance to Mescaline, LSD-25, and BOL-148Archives of General Psychiatry, 1959